{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T08:18:00Z","timestamp":1781770680842,"version":"3.54.5"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,8,19]],"date-time":"2015-08-19T00:00:00Z","timestamp":1439942400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13063-015-0891-y","type":"journal-article","created":{"date-parts":[[2015,8,18]],"date-time":"2015-08-18T12:45:08Z","timestamp":1439901908000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Long-term safety and efficacy of antithymocyte globulin induction: use of integrated national registry data to achieve ten-year follow-up of 10-10 Study participants"],"prefix":"10.1186","volume":"16","author":[{"given":"Krista L.","family":"Lentine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Schnitzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiling","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel C.","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,8,19]]},"reference":[{"issue":"4","key":"891_CR1","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.transproceed.2004.03.084","volume":"36","author":"MC Castro","year":"2004","unstructured":"Castro MC, Araujo LM, Nahas WC, Arap S, David-Neto E, Ianhez LE. Induction versus noninduction therapy in kidney transplantation: considering different PRA levels and different induction therapies. Transplant Proc. 2004;36(4):874\u20136.","journal-title":"Transplant Proc"},{"issue":"9","key":"891_CR2","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1097\/01.TP.0000100826.58738.2B","volume":"76","author":"WS Cherikh","year":"2003","unstructured":"Cherikh WS, Kauffman HM, McBride MA, Maghirang J, Swinnen LJ, Hanto DW. Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation. Transplantation. 2003;76(9):1289\u201393.","journal-title":"Transplantation"},{"issue":"Suppl 2","key":"891_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/ajt.13195","volume":"15","author":"AJ Matas","year":"2015","unstructured":"Matas AJ, Smith JM, Skeans MA, Thompson B, Gustafson SK, Schnitzler MA, et al. OPTN\/SRTR 2013 Annual Data Report: kidney. Am J Transplant. 2015;15 Suppl 2:1.","journal-title":"Am J Transplant."},{"key":"891_CR4","unstructured":"United States Renal Data System (USRDS). 2014 Annual Data Report. Chapter 6: Transplantation. Available at: http:\/\/www.usrds.org\/2014\/view\/v2_06.aspx . Accessed 1 July 2015."},{"key":"891_CR5","unstructured":"Administration USFaD. 1998 Approval Letter \u2013 Thymoglobulin. http:\/\/www.fda.gov\/BiologicsBloodVaccines\/BloodBloodProducts\/ApprovedProducts\/LicensedProductsBLAs\/FractionatedPlasmaProducts\/ucm117146.htm . Accessed 1 July 2015."},{"issue":"19","key":"891_CR6","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1056\/NEJMoa060068","volume":"355","author":"DC Brennan","year":"2006","unstructured":"Brennan DC, Daller JA, Lake KD, Cibrik D, Del Castillo D. Rabbit antithymocyte globulin versus basiliximab in renal transplantation. N Engl J Med. 2006;355(19):1967\u201377.","journal-title":"N Engl J Med"},{"issue":"17","key":"891_CR7","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1001\/jama.295.17.2072","volume":"295","author":"BL Strom","year":"2006","unstructured":"Strom BL. How the US drug safety system should be changed. JAMA. 2006;295(17):2072\u20135.","journal-title":"JAMA"},{"key":"891_CR8","unstructured":"Organ Procurement and Transplant Network. About OPTN Data. http:\/\/optn.transplant.hrsa.gov\/data\/ . Accessed 1 July 2015."},{"key":"891_CR9","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1111\/j.1600-6135.2005.00840.x","volume":"5","author":"DM Dickinson","year":"2004","unstructured":"Dickinson DM, Dykstra DM, Levine GN, Li S, Welch JC, Webb RL. Transplant data: sources, collection and research considerations, 2004. Am J Transplant. 2004;5:850\u201361.","journal-title":"Am J Transplant."},{"issue":"16","key":"891_CR10","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1056\/NEJMc0805714","volume":"359","author":"DC Brennan","year":"2008","unstructured":"Brennan DC, Schnitzler MA. Long-term results of rabbit antithymocyte globulin and basiliximab induction. N Engl J Med. 2008;359(16):1736\u20138.","journal-title":"N Engl J Med"},{"issue":"2","key":"891_CR11","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1097\/TP.0b013e31825475a3","volume":"94","author":"PA Clayton","year":"2012","unstructured":"Clayton PA, McDonald SP, Chapman JR, Chadban SJ. Mycophenolate versus azathioprine for kidney transplantation: a 15-year follow-up of a randomized trial. Transplantation. 2012;94(2):152\u20138.","journal-title":"Transplantation"},{"issue":"4","key":"891_CR12","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/TP.0b013e318259407f","volume":"94","author":"KL Lentine","year":"2012","unstructured":"Lentine KL, Gheorghian A, Axelrod D, Kalsekar A, L\u2019Italien G, Schnitzler MA. The implications of acute rejection for allograft survival in contemporary US kidney transplantation. Transplantation. 2012;94(4):369\u201376.","journal-title":"Transplantation"},{"issue":"3","key":"891_CR13","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1097\/TP.0b013e318255f839","volume":"94","author":"A Gheorghian","year":"2012","unstructured":"Gheorghian A, Schnitzler MA, Axelrod DA, Kalsekar A, L\u2019Italien G, Lentine KL. The implications of acute rejection and reduced allograft function on health care expenditures in contemporary US kidney transplantation. Transplantation. 2012;94(3):241\u20139.","journal-title":"Transplantation"},{"key":"891_CR14","first-page":"155A","volume":"11","author":"AS Levey","year":"2000","unstructured":"Levey AS, Greene T, Kusek JW, Beck G. A simplified equation to prediction glomerular filtration rate from serum creatinine. J Am Soc Nephrol. 2000;11:155A.","journal-title":"J Am Soc Nephrol."},{"issue":"2","key":"891_CR15","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1007\/s11606-010-1513-8","volume":"26","author":"E Walker","year":"2011","unstructured":"Walker E, Nowacki AS. Understanding equivalence and noninferiority testing. J Gen Intern Med. 2011;26(2):192\u20136.","journal-title":"J Gen Intern Med"},{"issue":"9","key":"891_CR16","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1097\/01.tp.0000179639.98338.39","volume":"80","author":"S Caillard","year":"2005","unstructured":"Caillard S, Dharnidharka V, Agodoa L, Bohen E, Abbott K. Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression. Transplantation. 2005;80(9):1233\u201343.","journal-title":"Transplantation"},{"issue":"9","key":"891_CR17","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1097\/01.tp.0000219817.18049.36","volume":"81","author":"G Opelz","year":"2006","unstructured":"Opelz G, Naujokat C, Daniel V, Terness P, Dohler B. Disassociation between risk of graft loss and risk of non-Hodgkin lymphoma with induction agents in renal transplant recipients. Transplantation. 2006;81(9):1227\u201333.","journal-title":"Transplantation"},{"issue":"6","key":"891_CR18","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1681\/ASN.2008101037","volume":"20","author":"C Noel","year":"2009","unstructured":"Noel C, Abramowicz D, Durand D, Mourad G, Lang P, Kessler M, et al. Daclizumab versus antithymocyte globulin in high-immunological-risk renal transplant recipients. J Am Soc Nephrol. 2009;20(6):1385\u201392.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"891_CR19","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1097\/SLA.0000000000000496","volume":"259","author":"NA Pilch","year":"2014","unstructured":"Pilch NA, Taber DJ, Moussa O, Thomas B, Denmark S, Meadows HB, et al. Prospective randomized controlled trial of rabbit antithymocyte globulin compared with IL-2 receptor antagonist induction therapy in kidney transplantation. Ann Surg. 2014;259(5):888\u201393.","journal-title":"Ann Surg"},{"issue":"12","key":"891_CR20","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1056\/NEJMp058029","volume":"352","author":"S Okie","year":"2005","unstructured":"Okie S. Safety in numbers \u2013 monitoring risk in approved drugs. N Engl J Med. 2005;352(12):1173\u20136.","journal-title":"N Engl J Med"},{"issue":"1","key":"891_CR21","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1097\/01.TP.0000132329.67611.3F","volume":"78","author":"KL Hardinger","year":"2004","unstructured":"Hardinger KL, Schnitzler MA, Miller B, Lowell JA, Shenoy S, Koch MJ, et al. Five-year follow up of thymoglobulin versus ATGAM induction in adult renal transplantation. Transplantation. 2004;78(1):136\u201341.","journal-title":"Transplantation"},{"issue":"2","key":"891_CR22","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.transproceed.2006.12.004","volume":"39","author":"B Kruger","year":"2007","unstructured":"Kruger B, Fischereder M, Jauch KW, Graeb C, Hoffmann U, Boger CA, et al. Five-year follow-up after late conversion from calcineurin inhibitors to sirolimus in patients with chronic renal allograft dysfunction. Transplant Proc. 2007;39(2):518\u201321.","journal-title":"Transplant Proc"},{"issue":"1","key":"891_CR23","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/01.tp.0000268084.64888.f3","volume":"84","author":"LE Kyllonen","year":"2007","unstructured":"Kyllonen LE, Eklund BH, Pesonen EJ, Salmela KT. Single bolus antithymocyte globulin versus basiliximab induction in kidney transplantation with cyclosporine triple immunosuppression: efficacy and safety. Transplantation. 2007;84(1):75\u201382.","journal-title":"Transplantation"},{"issue":"10","key":"891_CR24","first-page":"1526","volume":"68","author":"BD Kahan","year":"1999","unstructured":"Kahan BD, Julian BA, Pescovitz MD, Vanrenterghem Y, Neylan J. Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in Caucasian recipients of mismatched primary renal allografts: a Phase II trial. Rapamune Study Group Transplantation. 1999;68(10):1526\u201332.","journal-title":"Rapamune Study Group Transplantation"},{"issue":"2","key":"891_CR25","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1097\/00007890-200101270-00019","volume":"71","author":"AS MacDonald","year":"2001","unstructured":"MacDonald AS. A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus\/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts. Transplantation. 2001;71(2):271\u201380.","journal-title":"Transplantation"}],"updated-by":[{"DOI":"10.1186\/s13063-015-0940-6","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2015,9,16]],"date-time":"2015-09-16T00:00:00Z","timestamp":1442361600000}}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-015-0891-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13063-015-0891-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-015-0891-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,6]],"date-time":"2016-10-06T16:45:10Z","timestamp":1475772310000},"score":1,"resource":{"primary":{"URL":"http:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-015-0891-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,19]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["891"],"URL":"https:\/\/doi.org\/10.1186\/s13063-015-0891-y","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s13063-015-0940-6","asserted-by":"object"}]},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,19]]},"article-number":"365"}}